Odisha’s First Vaccine Manufacturing Plant ‘Sapigen Biologix’ To Start Production By May 2024

Bhubaneswar: Commercial production at the Sapigen Biologix vaccine plant in Odisha, the first such facility in the state, will commence by May this year, officials said on Sunday.

The plant at the Biotech Park in Andharua near here will have a capacity to produce 2.4 crore doses of different vaccines per day, they said.

At full capacity, this facility will be the biggest vaccine-producing plant in the country, the Chief Minister’s Office (CMO) said in a statement.

It is expected to produce over 15 vaccines for various diseases, including cholera and malaria.

The Rs 1,500-crore vaccine plant will create direct employment for 1,500 people, with most of them being local recruits, the CMO said.

The variety of vaccines produced in Bhubaneswar will be supplied to many parts of the world, it added.

V K Pandian, the chairman of ‘5T’ technology-led transformative initiatives on Sunday visited the sub-units and interacted with the management and employees. He urged all government agencies to assist in the commissioning of the plant within the next three months.

Related Posts

  • Pharma
  • April 24, 2024
  • 20 views
India Lifts Safeguard Measures On Isopropyl Alcohol Imports

Mumbai: The Directorate General of Foreign Trade (DGFT) has officially announced the discontinuation of safeguard measures on the import of isopropyl alcohol (IPA). The decision, communicated through Trade Notice dated April…

  • Pharma
  • April 24, 2024
  • 31 views
Punjab And Haryana HC Notice To Centre On Petition Against Misuse Of Oxytocin

Chandigarh: The Punjab and Haryana High Court today sought response from the Union and State government in PIL seeking implementation of Prevention of Cruelty to Animals Act, 1960 (Resignation of…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

India Lifts Safeguard Measures On Isopropyl Alcohol Imports

India Lifts Safeguard Measures On Isopropyl Alcohol Imports

Punjab And Haryana HC Notice To Centre On Petition Against Misuse Of Oxytocin

Punjab And Haryana HC Notice To Centre On Petition Against Misuse Of Oxytocin

Nepal Drugs Regulator To Conduct On-Site Testing Of Medicines

Nepal Drugs Regulator To Conduct On-Site Testing Of Medicines

‘Auric’ Relied On Amazon Reviews For Research Claims To Cure Fatty Liver

‘Auric’ Relied On Amazon Reviews For Research Claims To Cure Fatty Liver

Misleading Ads Case: Patanjali Issues Public Apology In A Daily Newspaper

Misleading Ads Case: Patanjali Issues Public Apology In A Daily Newspaper

AFMS Collaborates With IIT Delhi To Develop Medical Devices

AFMS Collaborates With IIT Delhi To Develop Medical Devices